Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2025376529-A1 · Dec 11, 2025 · US
This page is not indexed by search engines while we improve data quality.
Murawsky Christopher patents
Murawsky Christopher is listed as an inventor on 16 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Murawsky Christopher |
| Total patents | 16 |
| First publication | Mar 30, 2017 |
| Latest publication | Dec 11, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Anti-ASGR-1 monoclonal inhibitory antibodies
US-12331122-B2 · Jun 17, 2025 · US
Nucleic acid molecules encoding binding proteins for gastric inhibitory peptide receptor (GIPR)
US-12252540-B2 · Mar 18, 2025 · US
Chimeric receptors to DLL3 and methods of use thereof
US-12012462-B2 · Jun 18, 2024 · US
Non-terminal antibody discovery methods and single cell assays
US-2024103009-A1 · Mar 28, 2024 · US
Bispecific or biparatopic antigen binding proteins and uses thereof
US-2023137351-A1 · May 4, 2023 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2022025059-A1 · Jan 27, 2022 · US
Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof
US-11066472-B2 · Jul 20, 2021 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
US-11046774-B2 · Jun 29, 2021 · US
Chimeric receptors to dll3 and methods of use thereof
US-2021163621-A1 · Jun 3, 2021 · US
Recent patents
Latest publications not already listed above.
Asgr inhibitors
US-2021163601-A1 · Jun 3, 2021 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2019276546-A1 · Sep 12, 2019 · US
Asgr inhibitors
US-2019248902-A1 · Aug 15, 2019 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (GIPR) in combination with GLP-1 agonists
US-10294303-B2 · May 21, 2019 · US
Method of treating or ameliorating metabolic disorders using binding proteins for gastric inhibitory peptide receptor (gipr) in combination with glp-1 agonists
US-2017275370-A1 · Sep 28, 2017 · US
Asgr inhibitors
US-2017088620-A1 · Mar 30, 2017 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Amgen Inc | 16 |
| Kite Pharma Inc | 2 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C07K2317/565 | 15 |
| A61K2039/505 | 14 |
| C07K2317/21 | 13 |
| C07K2317/92 | 13 |
| C07K2317/76 | 13 |